A potential role for shed soluble major histocompatibility class I molecules as modulators of neurite outgrowth

Lorraine R Washburn1, Dan Zekzer, Shoshana Eitan

  • 1Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California, United States of America.

Plos One
|April 13, 2011
PubMed

Insights

Major histocompatibility class I (MHCI) molecules, when soluble, inhibit neuronal connection formation. This soluble MHCI

Area of Science:

  • Neurobiology
  • Immunology
  • Molecular Biology

Background:

  • The neurobiological functions of major histocompatibility class I (MHCI) molecules are not well understood.
  • MHCI molecules are known to be involved in immune responses and can be released in soluble forms (sMHCI).

Purpose of the Study:

  • To investigate the role of MHCI in the formation of neuronal connections.
  • To determine if soluble MHCI (sMHCI) affects neurite outgrowth.

Main Methods:

  • Cultured embryonic mouse retina and thalamic explants.
  • Utilized wildtype and transgenic mice (NSE-Db) with altered MHCI expression.
  • Analyzed neurite outgrowth in proximity to explants.
  • Investigated the effect of sMHCI from engineered cells on neuronal cultures.
  • Tested the impact of cAMP levels on sMHCI's neuroinhibitory effect.

Main Results:

  • Retina neurite outgrowth was significantly inhibited near thalami overexpressing MHCI.
  • The inhibitory factor released from these thalami was identified as sMHCI.
  • Engineered cells expressing MHCI released sMHCI that inhibited neurite outgrowth in vitro.
  • The neuroinhibitory effect of sMHCI was blocked by reducing cAMP levels.

Conclusions:

  • Soluble MHCI (sMHCI) acts as a neuroinhibitor, affecting neurite outgrowth.
  • Neuronal signaling pathways involving cyclic nucleotides may mediate MHCI's effects.
  • MHCI influences neural development not only in its membrane-bound form but also as a soluble molecule.